The convenience and ease of use of orforglipron will most likely enhance patient adherence and broaden the appeal of GLP-1 therapies to individuals who were previously hesitant about injectable treatments
This contributes to both its healing properties (maintaining blood supply to injured tissue) and its protective effects against various forms of organ damage
In addition to pharmacology, we used a chemogenetic approach to drive the activity of Glp1r -expressing neurons in the OB
The combination increases growth hormone levels, improving body composition, enhancing lean muscle mass, reducing fat, and speeding up recovery from injuries
As treatment continues and the dose increases, many patients report stronger hunger regulation and better control over eating habits
SELECT (semaglutide): 17,604 patients with established CV disease and overweight/obesity (without diabetes requirement)